×
返回 Agenda
Updates from the FDA
Speaker(s)
Peter Marks, MD, PhD
Senior Vice President, Molecul, Eli Lilly and Company, United States
Updates from the FDA
Nicole Verdun, MD
Director, Office of Therapeutic Products, CBER, FDA, United States
Updates from the FDA